Bram Ramaekers

17PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersFormal methods for softwareHealth policyMolecular targetsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 09, 2025
Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

Zakile A Mfumbilwa, Janneke A Wilschut, Harry J M Groen

|Mar 21, 2024
Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis.

Marie Westwood, Bram Ramaekers, Sabine Grimm

|Jan 09, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.

|Oct 12, 2023
Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP".

Sabine Elisabeth Grimm, Xavier G L V Pouwels, Bram L T Ramaekers

|Feb 09, 2023
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands.

Zakile A Mfumbilwa, Janneke A Wilschut, Martijn J H G Simons

|Aug 18, 2021
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.

Martijn J H G Simons, Valesca P Retèl, Bram L T Ramaekers

Pageof 3

Frequent Collaborators

5 joint publications

Manuela Joore

4 joint publications

Valesca Retèl

4 joint publications

Zakile A Mfumbilwa

4 joint publications

Veerle M H Coupé